Stem Cell Transplantation for Parkinson's Disease: Current Challenges and Perspectives
Xinlin Zeng1, Hua Qin1,2
11Nankai University, College of Life Sciences, Tianjin 300071, China.
Aging and Disease
|December 5, 2022
Summary
Stem cell transplantation shows promise for treating Parkinson's disease by replacing lost neurons. Future research aims to refine stem cell differentiation and understand their interaction with the brain's inflammatory environment.
Area of Science:
- Neuroscience
- Regenerative Medicine
Background:
- Parkinson's disease (PD) is a leading neurodegenerative disorder impacting millions globally.
- Current treatments manage symptoms but do not halt disease progression or restore lost neurons.
Purpose of the Study:
- To review the current state of stem cell transplantation for Parkinson's disease.
- To explore strategies for differentiating stem cells into dopaminergic neurons.
- To elucidate the mechanisms by which transplanted cells interact with the neuroinflammatory environment.
Main Methods:
- Review of existing literature on stem cell therapy for PD.
- Discussion of in vitro methods for stem cell differentiation into dopaminergic neurons.
- Analysis of the role of the brain's inflammatory microenvironment in cell transplantation outcomes.
Main Results:
- Stem cell transplantation offers potential for Parkinson's disease treatment.
- Controlling stem cell differentiation into dopaminergic neurons is achievable in vitro.
- Transplanted cells can modulate the inflammatory microenvironment to benefit neuronal survival.
Conclusions:
- Stem cell therapy is a promising avenue for Parkinson's disease.
- Further research should focus on optimizing directed differentiation and understanding neuro-immune interactions.
Related Concept Videos
01:24Parkinson's Disease: Treatment
343
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
343
01:15Parkinson's Disease: Overview
650
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
650
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
01:06Induced Pluripotent Stem Cells
4.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.3K
01:22Bone Marrow Sampling and Transplants
388
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
388